Sepp-Lorenzino Laura

CIK 00017774212 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001777421

Recent Transactions

50 trades

Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2025-06-02+113,246→ 113,246 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-06-02+56,623→ 105,843 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-03$12.18/sh−8,966→ 77,388 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-01+3,500→ 86,354 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2025-01-01−3,500→ 0 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2024-05-29+98,440→ 98,440 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-05-29+49,220→ 49,220 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-01+37,966→ 81,893 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-03-01+54,794→ 54,794 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-08$29.38/sh−667→ 43,927 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-08$28.66/sh−1,608→ 44,594 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$29.46/sh−5,532→ 46,202 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-01+3,500→ 51,734 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2024-01-01−3,500→ 3,500 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2023-06-22+36,200→ 36,200 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+29,938→ 47,567 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-03-01+42,302→ 42,302 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-05$38.22/sh−1,641→ 18,318 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-05$39.10/sh−689→ 17,629 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-04$37.21/sh−2,508→ 19,959 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-01+3,500→ 22,467 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2023-01-01−3,500→ 7,000 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-03-01+13,816→ 18,631 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+13,816→ 13,816 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+20,203→ 20,203 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01+3,500→ 5,963 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01$112.25/sh−1,148→ 4,815 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2022-01-01−3,500→ 10,500 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$158.90/sh−1,515→ 5,251 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$156.79/sh−7,425→ 10,698 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−70,000→ 80,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$154.77/sh−28,669→ 34,238 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$152.75/sh−15,839→ 83,552 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$159.64/sh−2,653→ 2,598 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$153.64/sh−20,645→ 62,907 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$14.25/sh+70,000→ 99,391 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$13.40/sh+27,000→ 29,391 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$160.47/sh−207→ 2,391 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$157.77/sh−3,932→ 6,766 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−27,000→ 82,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$155.61/sh−16,115→ 18,123 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$136.79/sh−6,814→ 20,106 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$140.73/sh−4,054→ 2,517 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$141.63/sh−126→ 2,391 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$13.40/sh+26,000→ 28,391 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$139.85/sh−2,772→ 6,571 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$137.72/sh−6,344→ 13,762 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-04−26,000→ 109,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-04$135.47/sh−1,471→ 26,920 total

Companies

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov